Clinical Trial Update: A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial updates the investigation of DC05F01 in Chinese patients with recurrent or refractory ovarian cancer and other advanced solid tumors. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• DC05F01

Snippet

Sponsor: Heronova Pharmaceuticals | Conditions: Solid Tumors, Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING